We Need to Solve THC Testing (The Daily Sentinel)
UF startup Cannabix Technologies gets a nod as “some light on the horizon” in this column by a Grand Junction, Colorado, attorney. My law practice predominantly involves helping people who have been injured in automobile accidents. One of the more difficult aspects is seeing the effect of people injured by drivers under the influence of […]
Blood Test May Eliminate Need for CT Scans after TBI (Healio)
The University of Rochester School of Medicine and Dentistry studied the accuracy of a TBI diagnostic blood test created by UF startup and Sid Martin Biotech graduate Banyan Biomarkers. A novel blood test predicted the absence of intracranial injuries on head CT scan after suspected traumatic brain injury with high accuracy, according to findings published […]
Breathtec to Open New Drug Development Division, Signs LOI to Acquire 100% of Clinical Stage Nash Pharmaceuticals Inc. (Globe Newswire)
UF startup Breathtec Biomedical Inc. is pleased to announce that it will be opening a new drug development division and has signed a Letter of Intent (“LOI”) to acquire 100% of the shares of Nash Pharmaceuticals Inc. Nash Pharma is a clinical stage pharmaceutical development company focused on drug repurposing in the areas of non-alcoholic […]
AgroFresh launches FreshCloud (FruitNet)
AgroFresh Solutions, a global leader in produce freshness solutions, has announced the launch of its FreshCloud platform, a data-backed, insights-driven solution for monitoring the quality of produce throughout the supply chain. The initiative has been made possible by AgroFresh’s acquisition of Verigo, a disruptive Internet of Things (IoT) company that offers end-to-end visibility and management […]
Cannabix Technologies Comments on Bill C-46 – Unaware of Any Material Change
UF startup Cannabix Technologies Inc., the developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, provides the following statement related to the government of Canada’s authorization of roadside saliva-testing devices under bill C-46: “It has been well signaled for some time by the Canadian government that a roadside saliva-testing device would be […]
Sun Biopharma, Inc. Presents Poster at Pancreasfest in Pittsburgh, Pa. (Globe Newswire)
UF startup Sun BioPharma, Inc., a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic diseases, announced the presentation of a poster reviewing the results of the Phase 1 Safety Study of its candidate drug, SBP-101, a polyamine metabolic inhibitor for pancreatic ductal adenocarcinoma (PDA) at PancreasFest in Pittsburgh, PA. […]
New Diagnostic Blood Test Developed for Concussions (eHealth News)
UF biotech company, Banyan Biomarkers, Inc. has developed the first blood test that can be used by physicians to objectively aid in the evaluation of patients with suspected traumatic brain injury (TBI) or concussions. Banyan is a University of Florida startup and a graduate of UF Innovate | Sid Martin Biotech. The Banyan Brain Trauma Indicator® […]
ViewRay Picks up Ex-Spectranetics CEO Drake, COO Matin | Personnel Moves (Mass Device)
UF startup ViewRay said it tapped former Spectranetics head Scott Drake as its new chief executive officer and former Spectranetics COO Shar Matin as its new COO. Before joining ViewRay, Drake served as CEO and prez of Spectranetics, which was acquired by Royal Philips in a deal that closed last August. Drake also serves as […]
Ology Bioservices and RAFA Laboratories Announce FDA Approval of the Atropine Autoinjector as a Medi (BioFlorida)
UF startup and Sid Martin Biotech alum Ology Bioservices, Inc., a biologics contract development and manufacturing organization, and Rafa Laboratories, Ltd., a leading Israeli pharmaceutical company, announced that on July 9, 2018, they received full approval from the U.S. Food and Drug Administration (FDA) for the Atropine Injection, 2mg/0.7mL, Single-Dose Autoinjector. The Atropine Autoinjector initially […]
AxoGen, Inc Common Stock (AXGN) Sets New 1-Year High at $56.85 (Fairfield Current)
UF startup and Sid Martin Biotech alum AxoGen, Inc reported that its Common Stock (NASDAQ:AXGN) shares hit a new 52-week high during mid-day trading on Tuesday. The company traded as high as $56.85 and last traded at $54.90, with a volume of 4762 shares changing hands. The stock had previously closed at $56.60. The company […]